Clinical Trial Update: Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating OBI-3424 in patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• OBI-3424

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING